Novel DNA vaccine offers broad protection against Influenza-A H3N
Researchers developed a novel DNA influenza vaccine based on four micro-consensus antigenic regions selected to represent the diversity of seasonal H3N2 viruses...
List view / Grid view
Researchers developed a novel DNA influenza vaccine based on four micro-consensus antigenic regions selected to represent the diversity of seasonal H3N2 viruses...
Researchers from Oxford have identified the initial steps on the path towards creating a universal influenza vaccine that could last for life...
A universal flu vaccine that protects people against most influenza strains is one step closer to reality...
Researchers have identified a new gene that plays a critical role in regulating the body's immune response to infection and disease...
Researchers show altering the molecular interactions between the flu virus and host genes stunts virus replication...
A group of researchers have discovered an important mechanism that governs how B cells are chosen to become plasma cells...
A new study from has shed light on just how viruses evolve so quickly and offers a potential way to slow them down...
RNA cells can be genetically programmed like a computer to fight cancer, influenza, and other serious conditions...
18 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Anti-inflammatory drugs, like those used to treat rheumatoid arthritis and psoriasis could in future be used to treat some cases of depression...
8 August 2016 | By St. Jude Children’s Research Hospital
Using vaccines prepared from killed viruses, the scientists targeted an influenza A H1N1 seasonal flu strain, finding that obese mice are not protected against influenza infections through vaccines, raising concerns about vaccine response in obese humans, who are known to be at an increased risk for severe flu...
25 July 2016 | By Niamh Louise Marriott, Digital Content Producer
Scientists have identified three types of vaccine-induced antibodies that can neutralise diverse strains of the flu virus that infect so many each year...
4 July 2016 | By Victoria White, Digital Content Producer
MIT engineers have developed easily customisable RNA vaccines that can be manufactured in one week and have shown efficacy against ebola and H1N1 influenza...
29 March 2016 | By Victoria White
Using a technique called COBRA, researchers created nine prototype synthetic compound vaccines constructed using genetic sequences from multiple influenza strains...
28 January 2016 | By Victoria White, Digital Content Producer, Drug Target Review
2015 was an exciting year for the drug discovery industry. Here we look at a selection of stories that particularly stood out for us…
10 December 2015 | By Victoria White
A team of scientists have tapped into publically available large-scale 'Omics' databases to identify new targets to treat influenza...